Alphamab Oncology (HK) Limited (3NK.F) Q3 2024 Earnings

15AugConfirmed
Q1 2024
Q3 2024
-0.01
0.33
0.66
0.99

Details

Expected EPS
N/A
Actual EPS
-0.00626799018
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Alphamab Oncology (HK) Limited (3NK.F) has reported earnings of -0.00626799018 per share for Q3 2024.

0 Comments

Share your thoughts